ilShinbiobase Co. Ltd (068330) - Net Assets
Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) has net assets worth ₩65.35 Billion KRW (≈ $44.29 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩72.69 Billion ≈ $49.26 Million USD) and total liabilities (₩7.33 Billion ≈ $4.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see ilShinbiobase Co. Ltd market capitalisation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩65.35 Billion |
| % of Total Assets | 89.91% |
| Annual Growth Rate | 9.3% |
| 5-Year Change | 28.39% |
| 10-Year Change | 96.45% |
| Growth Volatility | 8.79 |
ilShinbiobase Co. Ltd - Net Assets Trend (2013–2025)
This chart illustrates how ilShinbiobase Co. Ltd's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for ilShinbiobase Co. Ltd (2013–2025)
The table below shows the annual net assets of ilShinbiobase Co. Ltd from 2013 to 2025. See ilShinbiobase Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩64.80 Billion ≈ $43.91 Million |
+7.19% |
| 2024-12-31 | ₩60.45 Billion ≈ $40.97 Million |
+5.93% |
| 2023-12-31 | ₩57.06 Billion ≈ $38.67 Million |
+6.03% |
| 2022-12-31 | ₩53.82 Billion ≈ $36.47 Million |
+6.64% |
| 2021-12-31 | ₩50.47 Billion ≈ $34.20 Million |
+13.72% |
| 2020-12-31 | ₩44.38 Billion ≈ $30.08 Million |
+10.51% |
| 2019-12-31 | ₩40.16 Billion ≈ $27.22 Million |
+12.44% |
| 2018-12-31 | ₩35.72 Billion ≈ $24.20 Million |
+1.41% |
| 2017-12-31 | ₩35.22 Billion ≈ $23.87 Million |
+6.78% |
| 2016-12-31 | ₩32.98 Billion ≈ $22.35 Million |
+35.89% |
| 2015-12-31 | ₩24.27 Billion ≈ $16.45 Million |
-0.10% |
| 2014-12-31 | ₩24.30 Billion ≈ $16.47 Million |
+9.02% |
| 2013-12-31 | ₩22.29 Billion ≈ $15.10 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ilShinbiobase Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5828459185000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩58.28 Billion | 89.95% |
| Other Components | ₩6.51 Billion | 10.05% |
| Total Equity | ₩64.80 Billion | 100.00% |
ilShinbiobase Co. Ltd Competitors by Market Cap
The table below lists competitors of ilShinbiobase Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Qleanair Holding AB
ST:QAIR
|
$29.90 Million |
|
SEOJEON ELECTRIC MACHINERY Co.Ltd
KQ:189860
|
$29.91 Million |
|
Sustainable Power & Infrastructure Split Corp
TO:PWI
|
$29.92 Million |
|
Finetechnix. Co.Ltd
KQ:106240
|
$29.94 Million |
|
Naos Small Cap Opportunities Company Ltd
AU:NSC
|
$29.89 Million |
|
Bubang Co. Ltd
KQ:014470
|
$29.86 Million |
|
Tate & Lyle PLC
LSE:TATE
|
$29.86 Million |
|
Ajinextek Co. Ltd
KQ:059120
|
$29.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ilShinbiobase Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 60,449,711,460 to 64,796,478,850, a change of 4,346,767,390 (7.2%).
- Net income of 4,793,275,020 contributed positively to equity growth.
- Dividend payments of 291,737,300 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩4.79 Billion | +7.4% |
| Dividends Paid | ₩291.74 Million | -0.45% |
| Other Changes | ₩-154.77 Million | -0.24% |
| Total Change | ₩- | 7.19% |
Book Value vs Market Value Analysis
This analysis compares ilShinbiobase Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.68x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.84x to 0.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩1255.52 | ₩1058.00 | x |
| 2023-12-31 | ₩1369.20 | ₩1058.00 | x |
| 2024-12-31 | ₩1450.44 | ₩1058.00 | x |
| 2025-12-31 | ₩1554.74 | ₩1058.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ilShinbiobase Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.40%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 32.99%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.06x
- Recent ROE (7.40%) is below the historical average (8.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 4.49% | 10.25% | 0.36x | 1.21x | ₩-1.22 Billion |
| 2014 | 7.71% | 15.09% | 0.44x | 1.17x | ₩-555.43 Million |
| 2015 | 10.52% | 19.82% | 0.44x | 1.22x | ₩125.74 Million |
| 2016 | 8.16% | 20.15% | 0.35x | 1.14x | ₩-606.84 Million |
| 2017 | 5.98% | 16.40% | 0.33x | 1.09x | ₩-1.42 Billion |
| 2018 | 8.85% | 20.55% | 0.39x | 1.11x | ₩-410.68 Million |
| 2019 | 11.59% | 23.70% | 0.43x | 1.14x | ₩636.81 Million |
| 2020 | 10.09% | 21.29% | 0.42x | 1.12x | ₩40.92 Million |
| 2021 | 12.37% | 25.61% | 0.43x | 1.13x | ₩1.20 Billion |
| 2022 | 7.09% | 18.67% | 0.35x | 1.09x | ₩-1.57 Billion |
| 2023 | 10.92% | 37.92% | 0.27x | 1.06x | ₩526.09 Million |
| 2024 | 6.31% | 35.24% | 0.17x | 1.06x | ₩-2.23 Billion |
| 2025 | 7.40% | 32.99% | 0.21x | 1.06x | ₩-1.69 Billion |
Industry Comparison
This section compares ilShinbiobase Co. Ltd's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ilShinbiobase Co. Ltd (068330) | ₩65.35 Billion | 4.49% | 0.11x | $29.90 Million |
| Samyang Holdings Corp (000075) | $1.65 Trillion | 0.15% | 0.69x | $17.20 Million |
| POBIS TNC CO. Ltd (016670) | $48.55 Billion | 5.61% | 0.78x | $56.60 Million |
| Posco ICT Company Ltd (022100) | $368.64 Billion | 6.79% | 1.29x | $2.80 Billion |
| Osung Advanced Materials Co. Ltd (052420) | $58.20 Billion | -94.72% | 0.64x | $373.33 Million |
| Kyung Nam Pharm Co Ltd (053950) | $93.77 Billion | -8.35% | 0.47x | $10.44K |
| Kuk-Il Paper Mfg Co.Ltd (078130) | $39.03 Billion | -2.15% | 4.64x | $288.66 Million |
| OncoQuest Pharmaceuticals Inc (078590) | $34.70 Billion | 28.05% | 0.27x | $110.01 Million |
| MCNEX Co. Ltd (097520) | $323.61 Billion | 8.63% | 0.66x | $328.51 Million |
| Smac Co. Ltd (097780) | $225.35 Billion | 3.23% | 0.52x | $224.06 Million |
About ilShinbiobase Co. Ltd
ilShinbiobase Co. Ltd. manufactures and sells industrial refrigeration equipment in Korea. It offers laboratory, pilot, and plant scale, as well as auto loading/unloading systems; deep and quick freezers; and blood bank and pharmaceutical refrigerators. The company also provides ice makers and shakers. It also exports its products to approximately 100 countries. The company was formerly known as … Read more